QQ客服 官方微博 反馈留言

	RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway
	Liu, Mingming; Qi, Zihao; Liu, Bingzhi; Ren, Yi; Li, Hanbin; Yang, Gong; Zhang, Qian
刊名	ONCOTARGET
	2015
卷号	6期号:28
关键词	ovarian cancer anti-cancer agent isoflavone analog PI3K/AKT inhibition cytotoxicity
ISSN号	1949-2553
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4867965
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Liu, Mingming,Qi, Zihao,Liu, Bingzhi,et al. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway[J]. ONCOTARGET,2015,6(28).
APA	Liu, Mingming.,Qi, Zihao.,Liu, Bingzhi.,Ren, Yi.,Li, Hanbin.,...&Zhang, Qian.(2015).RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.ONCOTARGET,6(28).
MLA	Liu, Mingming,et al."RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway".ONCOTARGET 6.28(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。